Teva Pharmaceutical: An Opportunity Or A Falling Knife?

Teva Pharmaceutical Industries (TEVA) is the largest generic medicines pharmaceutical company in the world. It's estimated that one out of five prescriptions dispensed in the US belongs to TEVA.

For almost three decades - since it became publicly traded in early 1982 - TEVA rewarded its investors with phenomenal returns.

Even if you look at a chart that starts at 2000, you can see that for over ten years (until April 2010), TEVA has not only delivered great returns but also crushed any benchmark:


It's on us. Share your news here.

Submit your stories and articles to citybizlist today.